- Page 1 and 2:
Cancer Research in Switzerland A pu
- Page 3 and 4:
Cancer Research in Switzerland
- Page 5 and 6:
Basic biomedical research 55 Cancer
- Page 7 and 8:
policy work and was in charge of de
- Page 9 and 10:
The main focus of the research fund
- Page 11 and 12:
gramme research funding decreased b
- Page 13 and 14:
Table 2 Distribution of funds for i
- Page 15 and 16:
Funding patient-centred research Pa
- Page 17 and 18:
value was not clearly discernible.
- Page 19 and 20:
New organization of the Foundation
- Page 21 and 22:
The board of the Foundation Cancer
- Page 23 and 24:
The president of the Scientific Com
- Page 25 and 26:
Prof. Martin Pruschy, PhD Departmen
- Page 27 and 28:
Swartz wants to find out how tumour
- Page 29 and 30:
The scientific and medical research
- Page 31 and 32:
3. The original order/sequence of t
- Page 33 and 34:
As a federation, the Cancer League
- Page 35 and 36:
List of funded research projects, i
- Page 37 and 38:
Zippelius Alfred | 2009: CHF 100,00
- Page 39 and 40:
Kridel Robert | 2010: CHF 100,000.-
- Page 41 and 42:
Thurgau Cancer League Biotechnologi
- Page 43 and 44:
Weller Michael | 2010: CHF 65,828.-
- Page 45 and 46:
manageable funding of individual pr
- Page 47 and 48:
enhances breast cancer cell motilit
- Page 49 and 50:
Rüegg Curzio et al. | Tumor-mediat
- Page 51 and 52:
International Clinical Cancer Resea
- Page 53 and 54:
in PHIV were shown for Hodgkin’s
- Page 55:
Zucca Emanuele et al. | Internation
- Page 58 and 59:
56 “hierarchical structure” of
- Page 60 and 61:
58 the attempt should be made to st
- Page 62 and 63:
60 Gönczy Pierre | KLS 0202402
- Page 64 and 65: 62 Romero Pedro | OCS 020110220
- Page 66 and 67: 64 Beermann Friedrich | In vivo scr
- Page 68 and 69: 66 Christofori Gerhard | Podoplanin
- Page 70 and 71: 68 Frei Christian | The function of
- Page 72 and 73: 70 cell, this novel mechanism serve
- Page 74 and 75: 72 Results The induction of viral p
- Page 76 and 77: 74 Hübscher Ulrich | Repair of oxi
- Page 78 and 79: 76 Methods and experimental approac
- Page 80 and 81: 78 of cMyc and/or NMyc and demo
- Page 82 and 83: 80 In summary, this work improves o
- Page 84 and 85: 82 Pruschy Martin | Microtubule int
- Page 86 and 87: 84 Renner Christoph | Selective inh
- Page 88 and 89: 86 Goal Here we build on these obse
- Page 90 and 91: 88 by TDG prevents efficient downst
- Page 92 and 93: 90 To address these questions, we a
- Page 94 and 95: 92 Translational relevance The resu
- Page 96 and 97: 94 Grünberg Jürgen | KFS 025460
- Page 98 and 99: 96 Tschan Mario P. | KFS 0248608
- Page 100 and 101: 98 Boyman Onur | Preclinical testin
- Page 102 and 103: 100 Constam Daniel | Role of activi
- Page 104 and 105: 102 this study we will examine the
- Page 106 and 107: 104 Janscak Pavel | Study of the ro
- Page 108 and 109: 106 Müller Anne | The molecular pa
- Page 110 and 111: 108 Radtke Freddy | The role of Not
- Page 112 and 113: 110 Schär Primo | DNA repair, epig
- Page 116 and 117: 114
- Page 118 and 119: 116 and Research). Other financial
- Page 120 and 121: 118 be totally unaffordable for aca
- Page 122 and 123: 120 Clinical research List of compl
- Page 124 and 125: 122 Hunger Robert E. | OCS 02262-08
- Page 126 and 127: 124 Clinical research Presentation
- Page 128 and 129: 126 Benhattar Jean | Identification
- Page 130 and 131: 128 Bertoni Francesco | Genome-wide
- Page 132 and 133: 130 Interpretation ESA treatment in
- Page 134 and 135: 132 Our results could pave the way
- Page 136 and 137: 134 new drugs that specifically tar
- Page 138 and 139: 136 slides in two different concent
- Page 140 and 141: 138 Conclusions A strong network of
- Page 142 and 143: 140 tions introduced to ARE motifs
- Page 144 and 145: 142 Müller Beatrice U. | The maste
- Page 146 and 147: 144 A novel method was developed fo
- Page 148 and 149: 146 (SAKK 35-98) the Swiss Group fo
- Page 150 and 151: 148 Timmermann Beate | Prospective
- Page 152 and 153: 150 recurrence of the disease, we a
- Page 154 and 155: 152 Zucca Emanuele | A prospective
- Page 156 and 157: 154 Heinimann Karl | KFS 02489-08-2
- Page 158 and 159: 156 Riggi Nicolò | BIL KFS 02717-0
- Page 160 and 161: 158 activity at the single cell lev
- Page 162 and 163: 160 Our research projects aim at un
- Page 164 and 165:
162 Körner Meike | In vitro evalua
- Page 166 and 167:
164 Nadal David | Is endemic Burkit
- Page 168 and 169:
166 (> 50.000/patient). For their a
- Page 170 and 171:
168 Zeller Rolf | Functional analys
- Page 172 and 173:
170
- Page 174 and 175:
172 area of health services researc
- Page 176 and 177:
174 The financing of palliative car
- Page 178 and 179:
176 National Strategy for Palliativ
- Page 180 and 181:
178 Psychosocial research List of c
- Page 182 and 183:
180 Within the patient group, level
- Page 184 and 185:
182 Further, the results suggest th
- Page 186 and 187:
184 It is in this context that the
- Page 188 and 189:
186 Recommendation Female spouses o
- Page 190 and 191:
188 Psychosocial research Presentat
- Page 192 and 193:
190 rates communication skills rema
- Page 195 and 196:
Epidemiological research Epidemiolo
- Page 197 and 198:
data from cancer registries. In the
- Page 199 and 200:
The importance of cancer registries
- Page 201 and 202:
Ess Silvia | Patterns of care and s
- Page 203 and 204:
Epidemiological research List of ap
- Page 205 and 206:
Impact This work will serve as the
- Page 207 and 208:
Thürlimann Beat | Management of br